ID   NCC-DSM1-C1
AC   CVCL_C7G0
DR   Wikidata; Q117704720
RX   PubMed=36629983;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 39 hours (PubMed=36629983).
CC   Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Heterozygous (PubMed=36629983).
CC   Derived from site: In situ; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=36629983
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29,32
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C9182; Desmoid fibromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
RX   PubMed=36629983; DOI=10.1007/s13577-022-00850-x;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Osaki J., Ono T.,
RA   Adachi Y., Tsuchiya R., Toda Y., Kobayashi E., Kojima N., Yoshida A.,
RA   Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-DSM1-C1: a novel cell line
RT   derived from a patient with desmoid fibromatosis.";
RL   Hum. Cell 36:847-853(2023).
//